Effects of 1,25(OH)2D3 administration on serum bone GLA protein in predialysis chronic renal failure.
D000328:Adult; D000469:Alkaline Phosphatase / Q000097:blood; D001862:Bone Resorption; D002117:Calcitriol / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology*; D002118:Calcium / Q000097:blood; D002135:Calcium-Binding Proteins / Q000097:blood*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood* / Q000378:metabolism; D008875:Middle Aged; D010006:Osteoblasts / Q000187:drug effects* / Q000378:metabolism; D015675:Osteocalcin; D010281:Parathyroid Hormone / Q000097:blood; D010710:Phosphates / Q000097:blood
D002135:Calcium-Binding Proteins; D010281:Parathyroid Hormone; D010710:Phosphates; D015675:Osteocalcin; D000469:Alkaline Phosphatase; D002117:Calcitriol; D002118:Calcium